ロード中...
The effects of the location of cancer stem cell marker CD133 on the prognosis of hepatocellular carcinoma patients
BACKGROUND: CD133 (prominin-1) is widely believed to be a cancer stem cell marker in various solid tumor types, and CD133 has been correlated with tumor-initiating capacity. Recently, the nuclear location of CD133 expression in tumors has been discussed, but hepatocellular carcinoma (HCC) has not be...
保存先:
| 出版年: | BMC Cancer |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
BioMed Central
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5501948/ https://ncbi.nlm.nih.gov/pubmed/28687090 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-017-3460-9 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|